Cellply

Description

Cellply provides an automated single-cell analysis platform that profiles immune and cancer cells to support discovery and development of cell therapies and functional precision-medicine assays using microfluidics, robotics, imaging, and analysis.

Related

• ElyptaElypta develops standardized, scalable assays that quantify glycosaminoglycan (GAG) profiles in human biofluids to enable longitudinal…
• Camtech InnovationsCamtech Innovations develops and manufactures diagnostic assays, microfluidic chips and laboratory services for point-of-care diagnostics,…
• SuSoSSuSoS provides functional surface-coating design, prototyping, agile coating services, IP licensing, and technology transfers for…
• HealxHealx builds AI-driven drug discovery and development tools and therapies for rare disease patients, applying AI across discovery,…
• Cyted HealthCyted Health combines minimally invasive cell collection with molecular analysis to build diagnostic tests (EndoSign®) for earlier…
• NiumNium develops scalable gut-on-a-chip technology for microbiome discovery, using controlled microbial cultures, automated microfluidics, and…
• BICO GroupBICO Group provides lab automation software, purified ECM proteins, and 3D bioprinters used in tissue engineering, 3D bioprinting, cell…
• ImmaticsImmatics develops PRAME-targeted immunotherapies, advancing T-cell receptor cell therapies and bispecific molecules such as IMA203 and…
• IktosIktos builds generative AI and robotics systems for drug discovery, producing platforms for de novo molecule design, retrosynthesis…